Recent publications from the Linding lab in the University of Copenhagen’s (UCPH) Biotech Resource and Innovation Centre (BRIC) have shown a more extensive disruption of cell signaling pathways by cancer mutations than previously expected. Criexell et al. (2015) used a quantitative mass spectrometric-based phosphoproteomics approach in combination with exome next generation sequencing (NGS) to identify Read the rest of this article
The post Combining Phosphoproteomics with Exome NGS to Understand Cancer appeared first on Accelerating Science.
from Accelerating Science » Amanda Maxwell http://ift.tt/1JpXkAe